Correlation Between Bone Biologics and UFP Technologies

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and UFP Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and UFP Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and UFP Technologies, you can compare the effects of market volatilities on Bone Biologics and UFP Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of UFP Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and UFP Technologies.

Diversification Opportunities for Bone Biologics and UFP Technologies

-0.67

Correlation Coefficient

Bone Biologics  UFP Technologies

Excellent diversification

The 3 months correlation between Bone and UFP is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and UFP Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UFP Technologies and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with UFP Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UFP Technologies has no effect on the direction of Bone Biologics i.e., Bone Biologics and UFP Technologies go up and down completely randomly.

Pair Corralation between Bone Biologics and UFP Technologies

Given the investment horizon of 90 days Bone Biologics is expected to generate 1.13 times less return on investment than UFP Technologies. But when comparing it to its historical volatility, Bone Biologics Corp is 1.02 times less risky than UFP Technologies. It trades about 0.05 of its potential returns per unit of risk. UFP Technologies is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  25,327  in UFP Technologies on February 6, 2024 and sell it today you would earn a total of  873.00  from holding UFP Technologies or generate 3.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Bone Biologics Corp  vs.  UFP Technologies

Bone Biologics Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

UFP Technologies

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in UFP Technologies are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, UFP Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bone Biologics and UFP Technologies

The main advantage of trading using opposite Bone Biologics and UFP Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, UFP Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UFP Technologies will offset losses from the drop in UFP Technologies' long position.

The idea behind Bone Biologics Corp and UFP Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.